This is a sorely needed initiative that addresses some of the equity and access issues with Test-to-Treat as cases are rising once again in New York.
Category: healthcare
While Conservative Catholics Grab Media Attention On Abortion Issue, Liberal-Leaning Nuns Push Progressive Healthcare Causes Which Most Catholics Support
On July 7th, President Biden awarded Sister Simone Campbell the Presidential Medal of Freedom, the nation’s highest civilian honor. Campbell is executive director of a national Catholic social justice advocacy organization. She represents a longstandin…
Here’s How A Mississippi Case Could Keep Medication Abortion Legal Even In States That Have Banned It
A company that markets and sells abortion pills is arguing that banning them violates federal law.
Should You Get A Covid Booster? Here’s Who Should—And How.
It makes no sense to wait for an updated booster vaccine in fall and “leave yourself vulnerable” when there is lots of virus circulating, Dr. John Swartzberg, an infectious disease expert at the University of California at Berkeley, told Forbes.
How Older Patients, Their Families, And Medical Staffs Can Improve A Hospital Stay
Communication For patients: More than ever, you need an advocate.
InnovationRx: Teens And Mental Health; Plus, ‘All-In-One’ Vaccine
InnovationRx is your weekly digest of healthcare news. Sign up!
Pharmacists Can Prescribe Pfizer’s Covid Antiviral Paxlovid, FDA Says
The move comes as the White House pushes to make Covid-19 antiviral pills more widely available.
The Many Faces Of Omicron
As Omicron continues to evolve, here we analyze virological evolution in terms of new monoclonal antibody treatments.
Syphilis Is Rising—And May Not Be Recognized
Syphilis cases are rising rapidly nationally. Cases can be confused with monkeypox or herpes. Congenital syphilis cases are most worrisome, up nearly 15% from 2019 and 235% from 2016.
Brexafemme, New Treatment For Vaginal Yeast Infection, Faces Considerable Pricing And Reimbursement Challenges
Brexafemme is a recently approved drug for vaginal yeast infection; the first non-azole treatment. The drug’s sponsor, Scynexis, has made progress in the commercial market, facilitating access. But payer pricing and reimbursement challenges remain.
